-
Mashup Score: 12
Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists [Podcast]
Source: www.dovepress.comCategories: General Medicine NewsTweet
-
Mashup Score: 29
Our study provides data-driven technical insights for laboratories considering MFC AML MRD implementation and offers strong evidence supporting the utility of MRD assessment by MFC in patients with AML undergoing various stages of treatment and surveillance.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Our @MDAndersonNews experience Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort - @ArchivesPath #MRD #leusm #hemepath #AML https://t.co/B3NWm9G1Rk
-
-
Mashup Score: 45Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A - 20 day(s) ago
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around a…
Source: www.nature.comCategories: General Medicine NewsTweet-
RT @CKBrierley: 🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! https://t.co/7KJpQBsLWq We identified a targ…
-
-
Mashup Score: 45Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A - 21 day(s) ago
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around a…
Source: www.nature.comCategories: General Medicine NewsTweet-
RT @CKBrierley: 🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! https://t.co/7KJpQBsLWq We identified a targ…
-
-
Mashup Score: 44Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A - 21 day(s) ago
Nature Genetics – Multiomic analysis of blast-phase myeloproliferative neoplasms identifies a chromosome 21 amplicon harboring DYRK1A as a clonal and therapeutically targetable event in around a…
Source: www.nature.comCategories: General Medicine NewsTweet-
RT @CKBrierley: 🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! https://t.co/7KJpQBsLWq We identified a targ…
-
-
Mashup Score: 7The Tony Award Nominations - 23 day(s) ago
Search past winners and nominees, 1947 to the present. All Shows All In A Wonderful World: The Louis Armstrong Musical BOOP! The Musical Buena Vista Social Club Cult of Love Dead Outlaw Death Becomes Her Elf English Eureka Day Floyd Collins Glengarry Glen Ross Good Night, and Good Luck Gypsy The Hills of California Home JOB John Proctor is the Villain Just In Time The Last Five Years Left on Tenth Maybe Happy Ending McNeal Oh, Mary! Once Upon a Mattress Operation Mincemeat: A New Musical Othello Thornton
Source: www.tonyawards.comCategories: General Medicine NewsTweet-
Rooting for English (best play) and Sarah Snook (best actress in leading role) #TonyAwards #ThisIsBroadway https://t.co/hkUhsQpgJk
-
-
Mashup Score: 31Iranian filmmaker Jafar Panahi wins best film at Cannes - 1 month(s) ago
After decades of state censorship and imprisonment, the Iranian director won the prestigeous Palme d’Or for best film with his highly political piece “It Was Just an Accident.”
Source: www.dw.comCategories: General Medicine NewsTweet-
Iranian filmmaker Jafar Panahi wins best film at Cannes – DW – 05/24/2025 https://t.co/G0ipXtfoFF
-
-
Mashup Score: 10Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia - 1 month(s) ago
Sirenko et al. profile IDH1/2-mutated AML patients across disease stages (diagnosis, remission, and relapse) and treatments (targeted IDH inhibitors, chemotherapy, and hypomethylating agents). They delineate transcriptional programs associated with co-mutations (NPM1, SRSF2, and NRAS), treatment response, and relapse. Single-cell mutation tracking reveals the selection of rare diagnosis clones at relapse.
Source: www.cell.comCategories: General Medicine NewsTweet-
RT @CellStemCell: Online Now! Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia https://t.co/NXOv7GkyJK #…
-
-
Mashup Score: 10Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia - 1 month(s) ago
Sirenko et al. profile IDH1/2-mutated AML patients across disease stages (diagnosis, remission, and relapse) and treatments (targeted IDH inhibitors, chemotherapy, and hypomethylating agents). They delineate transcriptional programs associated with co-mutations (NPM1, SRSF2, and NRAS), treatment response, and relapse. Single-cell mutation tracking reveals the selection of rare diagnosis clones at relapse.
Source: www.cell.comCategories: General Medicine NewsTweet-
RT @CellStemCell: Online Now! Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia https://t.co/NXOv7GkyJK #…
-
-
Mashup Score: 46BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia - 2 month(s) ago
Key Points. A new clinical risk model in CMML, acronymized to BLAST, is easy to implement, globally applicable, and molecularly adaptiveMolecular informati
Source: ashpublications.orgCategories: General Medicine NewsTweet-
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia | Blood | American Society of Hematology @BloodJournal @MrinalPatnaik @GMontalbanBravo #CMML #hemepath https://t.co/YcUmCz0XYo
-
Podcast + companion paper .. enjoy!! #hemepath #LeuSM https://t.co/gHPdNJQc2I